Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
91
AWI Quote, Financials, Valuation and Earnings
Last price:
$159.61
Seasonality move
:
4.62%
Day range:
$158.93 - $160.94
52-week range:
$110.68 - $164.40
Dividend yield:
0.76%
P/E ratio:
25.52x
P/S ratio:
4.66x
P/B ratio:
8.73x
Volume:
228.3K
Avg. volume:
350.6K
1-year change:
39%
Market cap:
$6.9B
Revenue:
$1.4B
EPS (TTM):
$6.25
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $936.9M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Revenue Growth (YoY) | -9.75% | 18.11% | 11.43% | 5.04% | 11.62% | |
| Cost of Revenues | $603.8M | $701M | $784M | $798.2M | $864.1M | |
| Gross Profit | $333.1M | $405.6M | $449.1M | $497M | $581.6M | |
| Gross Profit Margin | 35.55% | 36.65% | 36.42% | 38.37% | 40.23% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $163.2M | $232.1M | $237M | $262.5M | $308.5M | |
| Other Inc / (Exp) | -$272.8M | $92M | $72.1M | $95.6M | $110M | |
| Operating Expenses | $163.2M | $232.1M | $237M | $262.5M | $308.5M | |
| Operating Income | $169.9M | $173.5M | $212.1M | $234.5M | $273.1M | |
| Net Interest Expenses | $23.8M | $22.8M | $26.6M | $31.8M | $36M | |
| EBT. Incl. Unusual Items | -$126.7M | $242.7M | $257.6M | $298.3M | $347.1M | |
| Earnings of Discontinued Ops. | -$15M | -$2.1M | $3M | -- | -- | |
| Income Tax Expense | -$42.6M | $57.4M | $57.7M | $74.5M | $82.2M | |
| Net Income to Company | -$99.1M | $183.2M | $202.9M | $223.8M | $264.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$99.1M | $183.2M | $202.9M | $223.8M | $264.9M | |
| Basic EPS (Cont. Ops) | -$2.07 | $3.84 | $4.38 | $5.00 | $6.06 | |
| Diluted EPS (Cont. Ops) | -$2.07 | $3.82 | $4.37 | $4.99 | $6.02 | |
| Weighted Average Basic Share | $47.9M | $47.6M | $46.3M | $44.7M | $43.7M | |
| Weighted Average Diluted Share | $47.9M | $47.9M | $46.4M | $44.8M | $44M | |
| EBITDA | -$18.6M | $362.1M | $368.4M | $422.8M | $490.1M | |
| EBIT | -$102.6M | $265.6M | $284.7M | $333.6M | $386.9M | |
| Revenue (Reported) | $936.9M | $1.1B | $1.2B | $1.3B | $1.4B | |
| Operating Income (Reported) | $169.9M | $173.5M | $212.1M | $234.5M | $273.1M | |
| Operating Income (Adjusted) | -$102.6M | $265.6M | $284.7M | $333.6M | $386.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $251.9M | $282.6M | $310.2M | $326.3M | $382.7M | |
| Revenue Growth (YoY) | 1.29% | 12.19% | 9.77% | 5.19% | 17.29% | |
| Cost of Revenues | $164.4M | $180.4M | $198.1M | $202M | $232.8M | |
| Gross Profit | $87.5M | $102.2M | $112.1M | $124.3M | $149.9M | |
| Gross Profit Margin | 34.74% | 36.16% | 36.14% | 38.09% | 39.17% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $54.2M | $57.1M | $62.7M | $65.4M | $78M | |
| Other Inc / (Exp) | $22.5M | $19.6M | $23.2M | $30.3M | $27.3M | |
| Operating Expenses | $54.2M | $57.1M | $62.7M | $65.4M | $78M | |
| Operating Income | $33.3M | $45.1M | $49.4M | $58.9M | $71.9M | |
| Net Interest Expenses | $5.7M | $5.1M | $8.7M | $9M | $8.5M | |
| EBT. Incl. Unusual Items | $49.7M | $59.4M | $63.9M | $80.2M | $90.7M | |
| Earnings of Discontinued Ops. | -$2.1M | -- | -- | -- | -- | |
| Income Tax Expense | $12.2M | $15M | $16.6M | $20.3M | $21.6M | |
| Net Income to Company | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Basic EPS (Cont. Ops) | $0.74 | $0.94 | $1.04 | $1.37 | $1.59 | |
| Diluted EPS (Cont. Ops) | $0.74 | $0.94 | $1.04 | $1.36 | $1.58 | |
| Weighted Average Basic Share | $47.8M | $47.1M | $45.4M | $43.8M | $43.5M | |
| Weighted Average Diluted Share | $48M | $47.2M | $45.5M | $44.1M | $43.8M | |
| EBITDA | $81M | $85.7M | $93.5M | $113.5M | $128.5M | |
| EBIT | $55.4M | $64.5M | $72.6M | $89.2M | $99.2M | |
| Revenue (Reported) | $251.9M | $282.6M | $310.2M | $326.3M | $382.7M | |
| Operating Income (Reported) | $33.3M | $45.1M | $49.4M | $58.9M | $71.9M | |
| Operating Income (Adjusted) | $55.4M | $64.5M | $72.6M | $89.2M | $99.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $940.1M | $1.1B | $1.3B | $1.3B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $610.8M | $717M | $801.7M | $802.1M | $894.9M | |
| Gross Profit | $329.3M | $420.3M | $459M | $509.2M | $607.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $182.6M | $235M | $242.6M | $265.2M | $320.9M | |
| Other Inc / (Exp) | $99.6M | $89.5M | $75.9M | $102.7M | $106.6M | |
| Operating Expenses | $182.6M | $235M | $242.6M | $265.2M | $320.9M | |
| Operating Income | $146.7M | $185.3M | $216.4M | $244M | $286.3M | |
| Net Interest Expenses | $22.8M | $22.2M | $30.2M | $32.1M | $35.5M | |
| EBT. Incl. Unusual Items | $223.1M | $252.4M | $262.1M | $314.6M | $357.6M | |
| Earnings of Discontinued Ops. | -$13.5M | -- | $3M | -- | -- | |
| Income Tax Expense | $47.1M | $60.2M | $59.3M | $78.2M | $83.5M | |
| Net Income to Company | $162.5M | $192.2M | $205.8M | $236.4M | $274.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $162.5M | $192.2M | $205.8M | $236.4M | $274.1M | |
| Basic EPS (Cont. Ops) | $3.39 | $4.04 | $4.48 | $5.34 | $6.28 | |
| Diluted EPS (Cont. Ops) | $3.39 | $4.02 | $4.47 | $5.32 | $6.25 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $337.6M | $366.8M | $376.2M | $442.8M | $505.1M | |
| EBIT | $246.2M | $274.7M | $292.8M | $350.2M | $396.9M | |
| Revenue (Reported) | $940.1M | $1.1B | $1.3B | $1.3B | $1.5B | |
| Operating Income (Reported) | $146.7M | $185.3M | $216.4M | $244M | $286.3M | |
| Operating Income (Adjusted) | $246.2M | $274.7M | $292.8M | $350.2M | $396.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $251.9M | $282.6M | $310.2M | $326.3M | $382.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $164.4M | $180.4M | $198.1M | $202M | $232.8M | |
| Gross Profit | $87.5M | $102.2M | $112.1M | $124.3M | $149.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $54.2M | $57.1M | $62.7M | $65.4M | $78M | |
| Other Inc / (Exp) | $22.5M | $19.6M | $23.2M | $30.3M | $27.3M | |
| Operating Expenses | $54.2M | $57.1M | $62.7M | $65.4M | $78M | |
| Operating Income | $33.3M | $45.1M | $49.4M | $58.9M | $71.9M | |
| Net Interest Expenses | $5.7M | $5.1M | $8.7M | $9M | $8.5M | |
| EBT. Incl. Unusual Items | $49.7M | $59.4M | $63.9M | $80.2M | $90.7M | |
| Earnings of Discontinued Ops. | -$2.1M | -- | -- | -- | -- | |
| Income Tax Expense | $12.2M | $15M | $16.6M | $20.3M | $21.6M | |
| Net Income to Company | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Basic EPS (Cont. Ops) | $0.74 | $0.94 | $1.04 | $1.37 | $1.59 | |
| Diluted EPS (Cont. Ops) | $0.74 | $0.94 | $1.04 | $1.36 | $1.58 | |
| Weighted Average Basic Share | $47.8M | $47.1M | $45.4M | $43.8M | $43.5M | |
| Weighted Average Diluted Share | $48M | $47.2M | $45.5M | $44.1M | $43.8M | |
| EBITDA | $81M | $85.7M | $93.5M | $113.5M | $128.5M | |
| EBIT | $55.4M | $64.5M | $72.6M | $89.2M | $99.2M | |
| Revenue (Reported) | $251.9M | $282.6M | $310.2M | $326.3M | $382.7M | |
| Operating Income (Reported) | $33.3M | $45.1M | $49.4M | $58.9M | $71.9M | |
| Operating Income (Adjusted) | $55.4M | $64.5M | $72.6M | $89.2M | $99.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $136.9M | $98.1M | $106M | $70.8M | $79.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $77.9M | $104.7M | $107.4M | $102.1M | $133M | |
| Inventory | $81.5M | $90.2M | $110M | $104M | $109.8M | |
| Prepaid Expenses | $12M | $17.2M | $16.6M | $15.9M | $19.8M | |
| Other Current Assets | $800K | $1.3M | $1.4M | $2.7M | $1.4M | |
| Total Current Assets | $311.8M | $321.9M | $356.5M | $313M | $348.9M | |
| Property Plant And Equipment | $569.5M | $582.2M | $589.2M | $618.2M | $670M | |
| Long-Term Investments | $50.8M | $59.7M | $31.6M | $25.7M | $38.2M | |
| Goodwill | $160.7M | $167M | $167.3M | $175.5M | $203.2M | |
| Other Intangibles | $457.5M | $421.4M | $407.7M | $412.4M | $455M | |
| Other Long-Term Assets | $48.1M | $48.2M | $44M | $41.2M | $39.1M | |
| Total Assets | $1.7B | $1.7B | $1.7B | $1.7B | $1.8B | |
| Accounts Payable | $81.3M | $105.8M | $105M | $91M | $132.4M | |
| Accrued Expenses | $16.7M | $28.9M | $37.6M | $27.3M | $33.3M | |
| Current Portion Of Long-Term Debt | $25M | $25M | -- | $22.5M | $22.5M | |
| Current Portion Of Capital Lease Obligations | $6.8M | $7.8M | $8.1M | $9.8M | $11.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $172.3M | $209.6M | $182.7M | $194.5M | $249.7M | |
| Long-Term Debt | $690.5M | $606.4M | $651.1M | $564.3M | $502.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Common Stock | $600K | $600K | $600K | $600K | $600K | |
| Other Common Equity Adj | -$109.3M | -$109.6M | -$100.1M | -$104.7M | -$110.2M | |
| Common Equity | $450.9M | $519.7M | $535M | $591.8M | $757.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $450.9M | $519.7M | $535M | $591.8M | $757.1M | |
| Total Liabilities and Equity | $1.7B | $1.7B | $1.7B | $1.7B | $1.8B | |
| Cash and Short Terms | $136.9M | $98.1M | $106M | $70.8M | $79.3M | |
| Total Debt | $715.5M | $631.4M | $651.1M | $586.8M | $525.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $121.6M | $76.1M | $96M | $69.6M | $82.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $92.7M | $109.9M | $118.7M | $120.5M | $148.2M | |
| Inventory | $81.9M | $103.9M | $113.4M | $106.4M | $117.1M | |
| Prepaid Expenses | $13.5M | $18.1M | $18.2M | $17.3M | $18.3M | |
| Other Current Assets | $1.6M | $900K | $1.1M | $3M | $1.3M | |
| Total Current Assets | $316.3M | $318.1M | $362M | $330.7M | $371.5M | |
| Property Plant And Equipment | $563.5M | $578.6M | $592.4M | $614.4M | $667.1M | |
| Long-Term Investments | $46.2M | $57.5M | $32M | $37M | $39.7M | |
| Goodwill | $166.5M | $167.1M | $167.3M | $175.3M | $210M | |
| Other Intangibles | $444.9M | $416.9M | $404.6M | $408.6M | $440.3M | |
| Other Long-Term Assets | $58.1M | $59.6M | $42.9M | $39.4M | $36.2M | |
| Total Assets | $1.7B | $1.7B | $1.7B | $1.7B | $1.9B | |
| Accounts Payable | $80.7M | $96.1M | $96.9M | $87.2M | $93.9M | |
| Accrued Expenses | $12.6M | $25M | $18.6M | $26.9M | $31M | |
| Current Portion Of Long-Term Debt | $25M | $25M | $5.6M | $22.5M | $22.5M | |
| Current Portion Of Capital Lease Obligations | $7.2M | $8.4M | $7.9M | $9.9M | $12.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $156.2M | $192.8M | $166.3M | $184.4M | $231.6M | |
| Long-Term Debt | $684.4M | $615.3M | $660.6M | $558.9M | $497.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B | |
| Common Stock | $600K | $600K | $600K | $600K | $600K | |
| Other Common Equity Adj | -$104.7M | -$97.7M | -$102.2M | -$105.6M | -$110.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $473.6M | $537.6M | $544.8M | $626.8M | $793.4M | |
| Total Liabilities and Equity | $1.7B | $1.7B | $1.7B | $1.7B | $1.9B | |
| Cash and Short Terms | $121.6M | $76.1M | $96M | $69.6M | $82.8M | |
| Total Debt | $709.4M | $640.3M | $666.2M | $581.4M | $519.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$99.1M | $183.2M | $202.9M | $223.8M | $264.9M | |
| Depreciation & Amoritzation | $84M | $96.5M | $83.7M | $89.2M | $103.2M | |
| Stock-Based Compensation | $6.8M | $11.3M | $14.3M | $18.8M | $18.3M | |
| Change in Accounts Receivable | $12.7M | -$30.9M | -$12.4M | -$1.6M | -$24.6M | |
| Change in Inventories | -$7.7M | -$10.6M | -$19.7M | $6.1M | $1.9M | |
| Cash From Operations | $218.8M | $187.2M | $182.4M | $233.5M | $266.8M | |
| Capital Expenditures | $55.4M | $79.8M | $74.8M | $83.8M | $82.8M | |
| Cash Acquisitions | -$109M | $77.6M | $101.7M | $70.4M | -$31.2M | |
| Cash From Investing | -$141.1M | -$13.9M | $28.2M | -$10.4M | -$79.3M | |
| Dividends Paid (Ex Special Dividend) | -$39.2M | -$41.4M | -$44.2M | -$46.9M | -$50.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $320M | $95M | $805M | $55M | $138M | |
| Long-Term Debt Repaid | -$218.1M | -$182.1M | -$785.9M | -$122.7M | -$203.8M | |
| Repurchase of Common Stock | -$44.4M | -$80M | -$167M | -$133.8M | -$59.9M | |
| Other Financing Activities | -- | -- | -$9.8M | -$10.2M | -$1.3M | |
| Cash From Financing | $13.5M | -$212.1M | -$201.9M | -$258.6M | -$177.6M | |
| Beginning Cash (CF) | $45.3M | $136.9M | $98.1M | $106M | $70.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $91.2M | -$38.8M | $8.7M | -$35.5M | $9.9M | |
| Ending Cash (CF) | $136.9M | $98.1M | $106M | $70.8M | $79.3M | |
| Levered Free Cash Flow | $163.4M | $107.4M | $107.6M | $149.7M | $184M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Depreciation & Amoritzation | $25.6M | $21.2M | $20.9M | $24.3M | $29.3M | |
| Stock-Based Compensation | $2.3M | $2.9M | $3.9M | $4.1M | $4.5M | |
| Change in Accounts Receivable | -$12.9M | -$13.1M | -$16.1M | -$25.1M | -$22.3M | |
| Change in Inventories | -$2.1M | -$13.6M | -$3.5M | -$2.5M | -$7.2M | |
| Cash From Operations | $19.6M | $16.7M | $26.2M | $26.4M | $41M | |
| Capital Expenditures | $13.2M | $12M | $22.3M | $14.7M | $19.1M | |
| Cash Acquisitions | $16.5M | $12.2M | $20.8M | $17.9M | $25.1M | |
| Cash From Investing | -$8.8M | $200K | -$1.5M | $5.9M | $6M | |
| Dividends Paid (Ex Special Dividend) | -$10.1M | -$10.9M | -$11.6M | -$12.3M | -$13.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $50M | $25M | $25M | $25M | $10M | |
| Long-Term Debt Repaid | -$56.8M | -$16.8M | -$10.6M | -$31.4M | -$16.4M | |
| Repurchase of Common Stock | -$10M | -$30M | -$27M | -$15M | -$22M | |
| Other Financing Activities | -- | -$6.7M | -$10.2M | -- | -$800K | |
| Cash From Financing | -$26.2M | -$39.2M | -$34.7M | -$33.1M | -$43.6M | |
| Beginning Cash (CF) | $136.9M | $98.1M | $106M | $70.8M | $79.3M | |
| Foreign Exchange Rate Adjustment | $100K | $300K | -- | -$400K | $100K | |
| Additions / Reductions | -$15.4M | -$22.3M | -$10M | -$800K | $3.4M | |
| Ending Cash (CF) | $121.6M | $76.1M | $96M | $69.6M | $82.8M | |
| Levered Free Cash Flow | $6.4M | $4.7M | $3.9M | $11.7M | $21.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $162.5M | $192.2M | $205.8M | $236.4M | $274.1M | |
| Depreciation & Amoritzation | $91.4M | $92.1M | $83.4M | $92.6M | $108.2M | |
| Stock-Based Compensation | $8.2M | $11.9M | $15.3M | $19M | $18.7M | |
| Change in Accounts Receivable | $12.3M | -$31.1M | -$15.4M | -$10.6M | -$21.8M | |
| Change in Inventories | -$8.8M | -$22.1M | -$9.6M | $7.1M | -$2.8M | |
| Cash From Operations | $212.7M | $184.3M | $191.9M | $233.7M | $281.4M | |
| Capital Expenditures | $56.6M | $78.6M | $85.1M | $76.2M | $87.2M | |
| Cash Acquisitions | -$110.6M | $73.3M | $110.3M | $67.5M | -$24M | |
| Cash From Investing | -$159.8M | -$4.9M | $26.5M | -$3M | -$79.2M | |
| Dividends Paid (Ex Special Dividend) | -$39.7M | -$42.2M | -$44.9M | -$47.6M | -$51.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $240M | $70M | $805M | $55M | $123M | |
| Long-Term Debt Repaid | -$254.9M | -$142.1M | -$779.7M | -$143.5M | -$188.8M | |
| Repurchase of Common Stock | -$20M | -$100M | -$164M | -$121.8M | -$66.9M | |
| Other Financing Activities | -- | -- | -$13.3M | -- | -- | |
| Cash From Financing | -$79.5M | -$225.1M | -$197.4M | -$257M | -$188.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$26.6M | -$45.7M | $21M | -$26.3M | $14.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $156.1M | $105.7M | $106.8M | $157.5M | $194.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $35.4M | $44.4M | $47.3M | $59.9M | $69.1M | |
| Depreciation & Amoritzation | $25.6M | $21.2M | $20.9M | $24.3M | $29.3M | |
| Stock-Based Compensation | $2.3M | $2.9M | $3.9M | $4.1M | $4.5M | |
| Change in Accounts Receivable | -$12.9M | -$13.1M | -$16.1M | -$25.1M | -$22.3M | |
| Change in Inventories | -$2.1M | -$13.6M | -$3.5M | -$2.5M | -$7.2M | |
| Cash From Operations | $19.6M | $16.7M | $26.2M | $26.4M | $41M | |
| Capital Expenditures | $13.2M | $12M | $22.3M | $14.7M | $19.1M | |
| Cash Acquisitions | $16.5M | $12.2M | $20.8M | $17.9M | $25.1M | |
| Cash From Investing | -$8.8M | $200K | -$1.5M | $5.9M | $6M | |
| Dividends Paid (Ex Special Dividend) | -$10.1M | -$10.9M | -$11.6M | -$12.3M | -$13.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $50M | $25M | $25M | $25M | $10M | |
| Long-Term Debt Repaid | -$56.8M | -$16.8M | -$10.6M | -$31.4M | -$16.4M | |
| Repurchase of Common Stock | -$10M | -$30M | -$27M | -$15M | -$22M | |
| Other Financing Activities | -- | -$6.7M | -$10.2M | -- | -$800K | |
| Cash From Financing | -$26.2M | -$39.2M | -$34.7M | -$33.1M | -$43.6M | |
| Beginning Cash (CF) | $136.9M | $98.1M | $106M | $70.8M | $79.3M | |
| Foreign Exchange Rate Adjustment | $100K | $300K | -- | -$400K | $100K | |
| Additions / Reductions | -$15.4M | -$22.3M | -$10M | -$800K | $3.4M | |
| Ending Cash (CF) | $121.6M | $76.1M | $96M | $69.6M | $82.8M | |
| Levered Free Cash Flow | $6.4M | $4.7M | $3.9M | $11.7M | $21.9M | |
Get AWI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AWI
Sector
P/E ratio
25.52x
17.84x
PEG ratio
1.46x
0.27x
P/B ratio
8.73x
1.70x
Price / LTM sales
4.66x
0.91x
Growth Metrics
AWI
Sector
Revenue growth
17.29%
2.21%
Earnings growth
16.18%
3.62%
Revenue (5-year growth)
6.85%
4.44%
Earnings forecast
$1.53
$0.29
Profitability
AWI
Sector
Profitability FY 2024
$581.6M
$406.4M
Return on invested capital
21.45%
5.51%
Return on assets
15.21%
3.56%
Return on equity
38.46%
8.69%
Earnings Date
Last Earnings Date
Apr
29
Next Earnings Date
Jul
30
Estimated Next Earnings Date
Jul
29
Balance Sheet
AWI
Sector
Total cash
$82.8M
$165.5M
Short term investments
--
$38.3M
Total assets
$1.8B
$1.9B
Long term debt
$519.7M
$282.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
